Caricamento...
Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy
OBJECTIVES: Obesity and diabetes are strong risk factors that drive the development of type I endometrial cancers. Recent epidemiological evidence suggests that metformin may lower cancer risk and reduce rates of cancer deaths among diabetic patients. In order to better understand metformin's a...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789879/ https://ncbi.nlm.nih.gov/pubmed/19822355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.09.024 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|